On the public citation graph
Current management of uveal melanoma: A review
0 signed · 161 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/archopht.118.9.1219openalex-snapshot
Plaque Radiotherapy for Uveal Melanoma Long-term Visual Outcome in 1106 Consecutive Patients
inferredcites →https://doi.org/10.1001/archopht.119.7.969openalex-snapshot
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality Findings
inferredcites →https://doi.org/10.1001/archopht.124.10.1428openalex-snapshot
Vascular Endothelial Growth Factor A in Eyes With Uveal Melanoma
inferredcites →https://doi.org/10.1001/archopht.124.12.1684openalex-snapshot
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma
inferredcites →https://doi.org/10.1001/jama.2014.6096openalex-snapshot
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma
inferredcites →https://doi.org/10.1001/jamaophthalmol.2015.0887openalex-snapshot
Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy
inferredcites →https://doi.org/10.1001/jamaophthalmol.2017.3805openalex-snapshot
Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas
inferredcites →https://doi.org/10.1007/s00262-011-1089-0openalex-snapshot
Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
inferredcites →https://doi.org/10.1007/s00347-006-1350-7openalex-snapshot
Verträglichkeit und Wirksamkeit einer adjuvanten Interferon-alfa-2b-Behandlung beim Aderhautmelanom
inferredcites →https://doi.org/10.1007/s00417-014-2735-yopenalex-snapshot
Proton beam therapy for presumed and confirmed iris melanomas: a review of 36 cases
inferredcites →https://doi.org/10.1007/s00417-014-2911-0openalex-snapshot
Egress of large quantities of heavy liquids from exposed choroid: a route for possible tumor dissemination via vortex veins in endoresection of choroidal melanoma
inferredcites →https://doi.org/10.1007/s00417-017-3834-3openalex-snapshot
Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy
inferredcites →https://doi.org/10.1007/s00417-018-3929-5openalex-snapshot
Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects
inferredcites →https://doi.org/10.1007/s10637-008-9143-2openalex-snapshot
O-Mel-Inib: A Cancéro-pôle Nord-Ouest multicenter phase II trial of high-dose Imatinib mesylate in metastatic uveal melanoma
inferredcites →https://doi.org/10.1007/s11912-017-0606-5openalex-snapshot
Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies
inferredcites →https://doi.org/10.1016/j.ajo.2004.07.006openalex-snapshot
The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24
inferredcites →https://doi.org/10.1016/j.ajo.2009.01.023openalex-snapshot
Effectiveness of Treatments for Metastatic Uveal Melanoma
inferredcites →https://doi.org/10.1016/j.ajo.2010.08.040openalex-snapshot
The Impact of Intravitreal Bevacizumab Therapy on Choroidal Melanoma
inferredcites →https://doi.org/10.1016/j.annonc.2020.10.552openalex-snapshot
64MO A phase (ph) II, multi-center study of the safety and efficacy of tebentafusp (tebe) (IMCgp100) in patients (pts) with metastatic uveal melanoma (mUM)
inferredcites →https://doi.org/10.1016/j.ijrobp.2012.12.022openalex-snapshot
Long-term Results of Carbon Ion Radiation Therapy for Locally Advanced or Unfavorably Located Choroidal Melanoma: Usefulness of CT-based 2-Port Orthogonal Therapy for Reducing the Incidence of Neovascular Glaucoma
inferredcites →https://doi.org/10.1016/j.jaapos.2011.10.012openalex-snapshot
Iris melanoma: Features and prognosis in 317 children and adults
inferredcites →https://doi.org/10.1016/j.meddos.2021.03.012openalex-snapshot
Dosimetric comparison and secondary malignancy risk estimation for linac-based and robotic stereotactic radiotherapy in uveal melanoma
inferredcites →https://doi.org/10.1016/j.ohc.2004.08.010openalex-snapshot
Uveal Melanoma: Resection Techniques
inferredcites →https://doi.org/10.1016/j.ophtha.2003.02.001openalex-snapshot
Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness
inferredcites →https://doi.org/10.1016/j.ophtha.2009.04.044openalex-snapshot
Adjuvant Interferon Therapy for Patients with Uveal Melanoma at High Risk of Metastasis
inferredcites →https://doi.org/10.1016/j.ophtha.2012.01.048openalex-snapshot
Detection and Time to Treatment of Uveal Melanoma in the United Kingdom: An Evaluation of 2384 Patients
inferredcites →https://doi.org/10.1016/j.ophtha.2012.10.021openalex-snapshot
Scleral Necrosis after Plaque Radiotherapy of Uveal Melanoma: A Case-Control Study
inferredcites →https://doi.org/10.1016/j.ophtha.2014.09.029openalex-snapshot
Primary Transpupillary Thermotherapy for Choroidal Melanoma in 391 Cases
inferredcites →https://doi.org/10.1016/j.ophtha.2017.08.017openalex-snapshot
Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma
inferredcites →https://doi.org/10.1016/j.ophtha.2020.01.032openalex-snapshot
The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma
inferredcites →https://doi.org/10.1016/j.survophthal.2003.08.001openalex-snapshot
Anterior segment tumors: current concepts and innovations
inferredcites →https://doi.org/10.1016/j.survophthal.2016.12.012openalex-snapshot
Radiotherapeutic and surgical management of iris melanoma: A review
inferredcites →https://doi.org/10.1016/j.survophthal.2022.05.002openalex-snapshot
Laser treatment for choroidal melanoma: Current concepts
inferredcites →https://doi.org/10.1016/j.yoph.2015.03.010openalex-snapshot
10.1016/j.yoph.2015.03.010
inferredcites →https://doi.org/10.1016/s0161-6420(00)00526-1openalex-snapshot
Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. visual acuity after 3 years COMS report no. 16
inferredcites →https://doi.org/10.1016/s0161-6420(01)00902-2openalex-snapshot
Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive cases: outcomes and limitations1 1The authors have no proprietary interests in any of the devices mentioned in this article.
inferredcites →https://doi.org/10.1016/s0161-6420(91)32194-8openalex-snapshot
Partial Lamellar Sclerouvectomy for Ciliary Body and Choroidal Tumors
inferredcites →https://doi.org/10.1038/bjc.2016.119openalex-snapshot
Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study
inferredcites →https://doi.org/10.1038/s41591-022-02015-7openalex-snapshot
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
inferredcites →https://doi.org/10.1056/nejmoa2103485openalex-snapshot
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
inferredcites →https://doi.org/10.1097/00132578-200104000-00007openalex-snapshot
Plaque Radiotherapy for Uveal Melanoma: Long-term Visual Outcome in 1,106 Consecutive Patients
inferredcites →https://doi.org/10.1097/01.iio.0000195856.31324.00openalex-snapshot
Neoadjuvant Proton Beam Radiotherapy Combined With Subsequent Endoresection of Choroidal Melanomas
inferredcites →https://doi.org/10.1097/01.iio.0000195862.71558.c8openalex-snapshot
The Role of Eyewall Resection in Uveal Melanoma Management
inferredcites →https://doi.org/10.1097/cmr.0000000000000519openalex-snapshot
20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas
inferredcites →https://doi.org/10.1097/cmr.0000000000000635openalex-snapshot
Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study
inferredcites →https://doi.org/10.1097/cmr.0b013e328358b373openalex-snapshot
A pilot study of sunitinib malate in patients with metastatic uveal melanoma
inferredcites →https://doi.org/10.1097/iae.0000000000001048openalex-snapshot
BRACHYTHERAPY ALONE OR WITH NEOADJUVANT PHOTODYNAMIC THERAPY FOR AMELANOTIC CHOROIDAL MELANOMA
inferredcites →https://doi.org/10.1097/iae.0b013e31824d09a8openalex-snapshot
CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES
inferredcites →https://doi.org/10.1097/icb.0000000000000021openalex-snapshot
FATAL AIR EMBOLISM DURING ENDORESECTION OF CHOROIDAL MELANOMA
inferredcites →https://doi.org/10.1097/icu.0000000000000761openalex-snapshot
Radiation therapy for uveal melanoma: a review of treatment methods available in 2021
inferredcites →https://doi.org/10.1111/aos.13418openalex-snapshot
Incidence of secondary glaucoma after treatment of uveal melanoma with robotic radiosurgery versus brachytherapy
inferredcites →https://doi.org/10.1111/j.1442-9071.1993.tb00759.xopenalex-snapshot
Laser photocoagulation treatment of choroidal melanoma
inferredcites →https://doi.org/10.1111/j.1755-3768.2010.01889.xopenalex-snapshot
Surgical treatment of iris and ciliary body melanoma: follow‐up of a 25‐year series of patients
inferredcites →https://doi.org/10.1111/j.1755-3768.2017.02343openalex-snapshot
Endoresectiopn of uveal melanoma without radiotherapy
inferredcites →https://doi.org/10.1136/bjo.2007.132951openalex-snapshot
Long-term results of primary transpupillary thermal therapy for the treatment of choroidal malignant melanoma
inferredcites →https://doi.org/10.1136/bjo.2009.162487openalex-snapshot
Ten-year results of transscleral resection of large uveal melanomas: local tumour control and metastatic rate
inferredcites →https://doi.org/10.1136/bjo.82.3.213openalex-snapshot
Endoresection of choroidal melanoma
inferredcites →https://doi.org/10.1136/bjophthalmol-2013-304022openalex-snapshot
Long-term outcome of primary endoresection of choroidal melanoma
inferredcites →https://doi.org/10.1136/bjophthalmol-2013-304432openalex-snapshot
Treatment of posterior uveal melanoma with multi-dose photodynamic therapy
inferredcites →https://doi.org/10.1136/jcp.2005.033613openalex-snapshot
Malignant melanoma of the ciliary body presenting as extraocular metastasis in the temporalis muscle
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-3227openalex-snapshot
Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11 -Dependent Manner
inferredcites →https://doi.org/10.1158/1078-0432.ccr-20-1247openalex-snapshot
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1159/000094834openalex-snapshot
Combined Proton Beam Radiotherapy and Transpupillary Thermotherapy for Large Uveal Melanomas: A Randomized Study of 151 Patients
inferredcites →https://doi.org/10.1159/000328257openalex-snapshot
Treatment of Uveal Melanoma by Accelerated Proton Beam
inferredcites →https://doi.org/10.1159/000450859openalex-snapshot
Growth of Uveal Melanoma following Intravitreal Bevacizumab
inferredcites →https://doi.org/10.1167/iovs.09-4755openalex-snapshot
Bevacizumab Suppression of Establishment of Micrometastases in Experimental Ocular Melanoma
inferredcites →https://doi.org/10.1177/1120672118776146openalex-snapshot
Regression patterns of choroidal melanoma: After palladium-103 ( 103 Pd) plaque brachytherapy
inferredcites →https://doi.org/10.1186/1477-3163-4-19openalex-snapshot
The role of c-kit and imatinib mesylate in uveal melanoma.
inferredcites →https://doi.org/10.1186/s12885-015-1470-zopenalex-snapshot
Study design and rationale for a randomised, placebo-controlled, double-blind study to assess the efficacy of selumetinib (AZD6244; ARRY-142886) in combination with dacarbazine in patients with metastatic uveal melanoma (SUMIT)
inferredcites →https://doi.org/10.1186/s12886-019-1108-zopenalex-snapshot
Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid
inferredcites →https://doi.org/10.1186/s13014-018-1088-9openalex-snapshot
Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma
inferredcites →https://doi.org/10.1200/jco.20.00605openalex-snapshot
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
inferredcites →https://doi.org/10.1200/jco.2016.34.15_suppl.3016openalex-snapshot
Safety, pharmacokinetics and efficacy of IMCgp100, a first-in-class soluble TCR-antiCD3 bispecific t cell redirector with solid tumour activity: Results from the FIH study in melanoma.
inferredcites →https://doi.org/10.1200/jco.2020.38.15_suppl.10075openalex-snapshot
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy.
inferredcites →https://doi.org/10.1371/journal.pone.0118564openalex-snapshot
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma
inferredcites →https://doi.org/10.3389/fonc.2022.976837openalex-snapshot
Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
inferredcites →https://doi.org/10.3390/biomedicines9101311openalex-snapshot
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review
inferredcites →https://doi.org/10.3390/cancers11060868openalex-snapshot
Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities
inferredcites →https://doi.org/10.3390/cancers11070971openalex-snapshot
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
inferredcites →https://doi.org/10.3390/cancers11081075openalex-snapshot
Uveal Melanoma Biopsy: A Review
inferredcites →https://doi.org/10.3390/cancers14010134openalex-snapshot
New Perspectives for Eye-Sparing Treatment Strategies in Primary Uveal Melanoma
inferredcites →https://doi.org/10.3390/ijms221810066openalex-snapshot
Vitreoretinal Surgery in the Prevention and Treatment of Toxic Tumour Syndrome in Uveal Melanoma: A Systematic Review
inferredcites →https://doi.org/10.3928/0090-4481-19881101-04openalex-snapshot
Surgical Approach to Lamellar Sclerouvectomy for Posterior Uveal Melanomas: The 1986 Schoenberg Lecture
inferredcites →https://doi.org/10.3928/1542-8877-19881101-04openalex-snapshot
Surgical Approach to Lamellar Sclerouvectomy for Posterior Uveal Melanomas: The 1986 Schoenberg Lecture
inferredcites →https://doi.org/10.3928/1542-8877-19910501-13openalex-snapshot
Orbital Exenteration With Eyelid Sparing: Indications, Technique, and Results
inferredcites →https://doi.org/10.4103/0974-9233.65494openalex-snapshot
Exoresection and endoresection for uveal melanoma
inferredcites →https://doi.org/10.4103/meajo.meajo_73_18openalex-snapshot
Choroidal melanoma resection
inferredcites →https://doi.org/10.5114/jcb.2019.87407openalex-snapshot
Complications and adverse events of plaque brachytherapy for ocular melanoma
inferredcites →https://doi.org/10.5114/jcb.2021.106191openalex-snapshot
Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
inferredcites →https://doi.org/10.5693/djo.02.2020.06.001openalex-snapshot
Rapid growth of primary uveal melanoma following intravitreal bevacizumab injection: a case report and review of the literature
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4857163openalex-extracted
Therapeutic Applications of Artemisinin in Ophthalmic Diseases
inferred← citeshttps://doi.org/10.1002/advs.77396openalex-snapshot
Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma
inferred← citeshttps://doi.org/10.1002/cnr2.70425openalex-snapshot
Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma
inferred← citeshttps://doi.org/10.1002/jbio.70241openalex-snapshot
Label‐Free Identification of Choroidal Melanoma Infiltration Boundaries Using Multiphoton Microscopy Combined With Image Analysis
inferred← citeshttps://doi.org/10.1007/s00066-025-02449-1openalex-snapshot
Non-invasive prediction of the secondary enucleation risk in uveal melanoma based on pretreatment CT and MRI prior to stereotactic radiotherapy
inferred← citeshttps://doi.org/10.1007/s00347-024-02060-2openalex-snapshot
Vital erscheinender Resttumor eines Aderhautmelanoms nach Protonenbestrahlung
inferred← citeshttps://doi.org/10.1007/s10118-025-3371-1openalex-snapshot
Nanocomposite from Alpha-Tocopheryl Succinate and Chitosan-modified-graphene for Efficient Inhibition on Choroidal Melanoma via a Chemotherapy-assisted-photothermal Therapy
inferred← citeshttps://doi.org/10.1007/s10142-026-01846-8openalex-snapshot
Ferroptosis-related ceRNA axis regulates the apoptosis and proliferation of uveal melanoma cells through MAPRE2
inferred← citeshttps://doi.org/10.1007/s12094-026-04499-yopenalex-snapshot
Gene therapy for uveal melanoma
inferred← citeshttps://doi.org/10.1007/s40137-025-00483-7openalex-snapshot
Ocular Melanoma: an Update on Surgical Approaches To Diagnosis, Characterization, and Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-443-15583-3.00041-xopenalex-snapshot
Choroidal melanoma
inferred← citeshttps://doi.org/10.1016/b978-0-443-27541-8.00004-3openalex-snapshot
Emerging therapies: Targeted and immunotherapy for eye melanoma
inferred← citeshttps://doi.org/10.1016/j.ajo.2024.11.018openalex-snapshot
Surgical Costs of Enucleation Versus Plaque Brachytherapy for Intraocular Malignancy: A Time-Driven Activity-Based Costing Approach
inferred← citeshttps://doi.org/10.1016/j.aopr.2024.03.005openalex-snapshot
Personalized treatment approaches in intraocular cancer
inferred← citeshttps://doi.org/10.1016/j.aopr.2024.10.001openalex-snapshot
Global incidence and prevalence in uveal melanoma
inferred← citeshttps://doi.org/10.1016/j.bbcan.2024.189104openalex-snapshot
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.canlet.2025.217531openalex-snapshot
Extracellular vesicles in uveal melanoma - Biological roles and diagnostic value
inferred← citeshttps://doi.org/10.1016/j.ejphar.2025.178472openalex-snapshot
Exploring copper metabolism and cuproptosis, and their implications in ocular diseases
inferred← citeshttps://doi.org/10.1016/j.exer.2024.110084openalex-snapshot
Evaluation of the effects of vitamin D analogs, bevacizumab, and radiotherapy in uveal melanoma cells
inferred← citeshttps://doi.org/10.1016/j.exer.2026.111043openalex-snapshot
Long non-coding RNA MIAT functions as a ceRNA to protect uveal melanoma from oxidative stress by sponging miR-4306 and upregulating CXCR4
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e42066openalex-snapshot
Therapeutic applications of artemisinin in ophthalmic diseases
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.132086openalex-snapshot
Injectable hydrogels based on biopolymers for the treatment of ocular diseases
inferred← citeshttps://doi.org/10.1016/j.jcjo.2024.07.004openalex-snapshot
Ophthalmic rehabilitation in oncology care
inferred← citeshttps://doi.org/10.1016/j.jid.2026.03.036openalex-snapshot
Uveal melanoma: A review of current treatment limitations and the emerging therapeutic potential of natural killer cells
inferred← citeshttps://doi.org/10.1016/j.semcancer.2025.10.002openalex-snapshot
The emerging role of metabolic interventions in uveal melanoma
inferred← citeshttps://doi.org/10.1038/s41418-025-01469-9openalex-snapshot
Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma
inferred← citeshttps://doi.org/10.1038/s41591-026-04518-zopenalex-snapshot
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial
inferred← citeshttps://doi.org/10.1080/14796678.2026.2680047openalex-snapshot
Systemic cardiac migration of perfluorocarbon liquid following unsuccessful endoresection of choroidal melanoma: a case report
inferred← citeshttps://doi.org/10.1111/ceo.14328openalex-snapshot
Uveitis masquerade syndromes: An approach to diagnosis
inferred← citeshttps://doi.org/10.1111/ceo.14380openalex-snapshot
Cysts and tumours of the iris: Diagnostic tools and key management considerations—A review
inferred← citeshttps://doi.org/10.1111/ceo.70015openalex-snapshot
Clinical and Experimental Ophthalmology Goes Paperless in 2026
inferred← citeshttps://doi.org/10.1111/ceo.70126openalex-snapshot
Long‐Term Local Control and Mortality After Transpupillary Thermotherapy of Small Uveal Melanomas
inferred← citeshttps://doi.org/10.1111/ceo.70139openalex-snapshot
Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques ‐ Review
inferred← citeshttps://doi.org/10.1159/000540844openalex-snapshot
Clinical Features and Initial Management Outcomes of Uveal Melanomas in a Single Tertiary Center in Egypt
inferred← citeshttps://doi.org/10.1159/000549336openalex-snapshot
Aurora Kinases in Ocular Malignancies: Functional Significance and Potential Implications
inferred← citeshttps://doi.org/10.1159/000552152openalex-snapshot
Characteristics and Outcomes of Patients with Early or Late Uveal Melanoma Metastasis: A Review
inferred← citeshttps://doi.org/10.1159/000553241openalex-snapshot
National Coordinated Care and Translational Research Program for Uveal Melanoma Pilot: Infrastructure, Biobanking, and Challenges in Liquid Biopsy Implementation in a Latin American Country
inferred← citeshttps://doi.org/10.1177/24741264261474157openalex-snapshot
Sequential Application of Transpupillary Thermal Therapy and Cryotherapy in the Management of Small Choroidal Melanoma: A Pilot Evaluation of Efficacy and Safety
inferred← citeshttps://doi.org/10.1186/s12935-026-04257-8openalex-snapshot
Multi-omics data reveal B cell regulated immune heterogeneity of MIF signaling pathway in uveal melanoma
inferred← citeshttps://doi.org/10.1186/s12951-025-03851-8openalex-snapshot
Melanoma treatment in the era of nanotechnology and precision medicine
inferred← citeshttps://doi.org/10.1186/s40644-025-00945-2openalex-snapshot
Diagnostic value of 18F-FDG PET/CT in the follow-up of metastatic uveal melanoma
inferred← citeshttps://doi.org/10.1371/journal.pone.0328360openalex-snapshot
Factors associated with time until metastatic spread in patients with primary uveal melanoma: A retrospective analysis
inferred← citeshttps://doi.org/10.18502/dmj.v9i1.21127openalex-snapshot
Orbital Metastasis from Prostatic Carcinoma Causing Proptosis: A Changing Picture
inferred← citeshttps://doi.org/10.18632/oncotarget.28586openalex-snapshot
GZ17-6.02 kills PDX isolates of uveal melanoma
inferred← citeshttps://doi.org/10.20517/mns.2025.10openalex-snapshot
Stimuli-responsive hydrogels for ocular tumor therapy
inferred← citeshttps://doi.org/10.21203/rs.3.rs-5718647/v1openalex-snapshot
JTC801 regresses uveal melanoma progression through novel methuosis-like cell death via lysosomal dysfunction
inferred← citeshttps://doi.org/10.21518/ms2025-255openalex-snapshot
Efficacy of combination immunotherapy in patients with generalized uveal melanoma: real clinical practice
inferred← citeshttps://doi.org/10.2174/0109298673286788240123044411openalex-snapshot
Significance of Aneuploidy in Predicting Prognosis and Treatment Response of Uveal Melanoma
inferred← citeshttps://doi.org/10.2174/0118756921412414251129122025openalex-snapshot
Precision Medicine in Eye Melanoma: Advancing Targeted Therapies and Personalized Care
inferred← citeshttps://doi.org/10.3389/fmed.2025.1687291openalex-snapshot
Insights into shape of uveal melanoma: a comprehensive evaluation of clinical features, pathological features, and prognosis analysis
inferred← citeshttps://doi.org/10.3389/fonc.2025.1605916openalex-snapshot
Clinical decision-making for uveal melanoma radiotherapy: comparative performance of experienced radiation oncologists and leading generative AI models
inferred← citeshttps://doi.org/10.3389/fonc.2026.1850655openalex-snapshot
Case Report: Synchronous germline BAP1-negative choroidal melanoma and clear cell renal cell carcinoma characterized by pan-cancer genomic profiling
inferred← citeshttps://doi.org/10.3390/biomedicines13010108openalex-snapshot
Oncolytic Viruses and Immunotherapy for the Treatment of Uveal Melanoma and Retinoblastoma: The Current Landscape and Novel Advances
inferred← citeshttps://doi.org/10.3390/cancers16234002openalex-snapshot
Into the Future: Fighting Melanoma with Immunity
inferred← citeshttps://doi.org/10.3390/cancers18010095openalex-snapshot
Vitreoretinal Surgery for Intraocular Complications Following Radiotherapy Treatment of Uveal Melanoma
inferred← citeshttps://doi.org/10.3390/cancers18121891openalex-snapshot
Oncogenic Gαq Signaling Remodels the Tumor Surfaceome and Rewires Intracellular Networks in Uveal Melanoma Models
inferred← citeshttps://doi.org/10.3390/cancers18152402openalex-snapshot
Redox Homeostasis, Metabolic Pathways and Plasticity in Uveal Melanoma Compared to Other Cancers
inferred← citeshttps://doi.org/10.3390/cancers18172826openalex-snapshot
A Possible Link Between Cutaneous Melanoma and Uveal Melanoma: A Multicenter Retrospective Cohort Study
inferred← citeshttps://doi.org/10.3390/curroncol32120688openalex-snapshot
Endoresection in Choroidal Melanoma: Outcomes of Intentional Incomplete Tumor Removal
inferred← citeshttps://doi.org/10.3390/ijms241612957openalex-snapshot
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies
inferred← citeshttps://doi.org/10.3390/jcm14124058openalex-snapshot
A Brief Overview of Uveal Melanoma Treatment Methods with a Focus on the Latest Advances
inferred← citeshttps://doi.org/10.3390/jmp6020007openalex-snapshot
Current Topics on the Integration of Artificial Intelligence in the Histopathological and Molecular Diagnosis of Uveal Melanoma
inferred← citeshttps://doi.org/10.35339/ekm.2025.94.3.dpaopenalex-snapshot
Clinical and histomorphological characteristics of medium and large-sized uveal melanoma stages T1–3 after failure of organ-preserving treatment
inferred← citeshttps://doi.org/10.3892/ol.2024.14636openalex-snapshot
Identification of feature genes and molecular mechanisms involved in cell communication in uveal melanoma through analysis of single‑cell sequencing data
inferred← citeshttps://doi.org/10.4103/mgmj.mgmj_164_25openalex-snapshot
A histopathological spectrum of orbital and ocular lesions: a study from a tertiary care center in central India
inferred← citeshttps://doi.org/10.7150/jca.101823openalex-snapshot
A novel EMT-related risk score model for Uveal melanoma based on ZNF667-AS1 and AP005121.1
inferred← citeshttps://doi.org/10.7759/cureus.109650openalex-snapshot
Don’t Miss the Blind Spots: Incidental Detection of Choroidal Melanoma During Primary Care Evaluation of Visual Field Loss
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.